vialaudit
The Roundup
melanotan ii · massachusetts

Is Melanotan II legal in Massachusetts?

status · caveats apply
No FDA approval; foundational FDA enforcement target (2007 Melanocorp case); not on 2026 WADA Prohibited List but cosmetic/therapeutic claims trigger FDCA §301. No state-level peptide restrictions beyond federal law in Massachusetts.

category: no approval · last verified May 13, 2026

§ 01

Quick answer

No FDA approval; foundational FDA enforcement target (2007 Melanocorp case); not on 2026 WADA Prohibited List but cosmetic/therapeutic claims trigger FDCA §301. No state-level peptide restrictions beyond federal law in Massachusetts.
§ 02

Full status breakdown

Federal status

FDA approval
no approval
DEA scheduling
not scheduled
503A compounding
Bulks list: not on list
Do-not-compound list: not on list
Was on Category 2 (significant safety risks). Per April 2026 administrative update, MT-2 was among 12 peptides removed from Category 2 after nominator withdrawals. No PCAC vote.
FDA Warning Letters
  • Aug 30, 2007 — Melanocorp Inc. (cited: melanotan-2) · letter ↗
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: Foundational FDA enforcement target (Melanocorp 2007). Selling MT-2 with cosmetic/therapeutic claims is direct FDCA §301 violation. Even with RUO disclaimers, FDA has prosecuted sellers when 'research' framing is pretextual.
Personal possession: Not federally criminalized. UK MHRA has stricter enforcement.

Massachusetts — state-specific

Sport-body status

WADA 2026
not on prohibited list
Not explicitly named. Melanocortin receptor agonists are not a standalone S-class.
USADA
unknown
NCAA
unknown

What we couldn’t verify

§ 03

Also known as

Melanotan II is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):

  • MT-2
  • MT-II
  • Melanotan-2
  • MTII
  • cyclic α-MSH analogue
§ 04

Disclaimer

§ 05

Related

the roundup · monthly

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 subscribers· 0 sponsored items· 11 issues since launch